4//SEC Filing
Claremount VII Associates, L.P. 4
Accession 0000899243-21-034820
CIK 0001568651other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 7:56 PM ET
Size
19.9 KB
Accession
0000899243-21-034820
Insider Transaction Report
Form 4
Transactions
- Purchase
Class A Common Stock
2021-08-30$14.68/sh+274,697$4,033,761→ 1,997,676 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$15.43/sh+211,703$3,267,170→ 2,358,403 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$14.81/sh+93,836$1,389,861→ 2,146,700 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-30$15.27/sh+55,188$842,770→ 2,052,864 total(indirect: See footnote)
Thrive Partners VII Growth GP, LLC
10% Owner
Transactions
- Purchase
Class A Common Stock
2021-08-30$15.27/sh+55,188$842,770→ 2,052,864 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$15.43/sh+211,703$3,267,170→ 2,358,403 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-30$14.68/sh+274,697$4,033,761→ 1,997,676 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$14.81/sh+93,836$1,389,861→ 2,146,700 total(indirect: See footnote)
Thrive Partners VII GP, LLC
10% Owner
Transactions
- Purchase
Class A Common Stock
2021-08-30$15.27/sh+55,188$842,770→ 2,052,864 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$14.81/sh+93,836$1,389,861→ 2,146,700 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$15.43/sh+211,703$3,267,170→ 2,358,403 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-30$14.68/sh+274,697$4,033,761→ 1,997,676 total(indirect: See footnote)
Claremount VII Associates, L.P.
10% Owner
Transactions
- Purchase
Class A Common Stock
2021-08-30$15.27/sh+55,188$842,770→ 2,052,864 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-30$14.68/sh+274,697$4,033,761→ 1,997,676 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$14.81/sh+93,836$1,389,861→ 2,146,700 total(indirect: See footnote) - Purchase
Class A Common Stock
2021-08-31$15.43/sh+211,703$3,267,170→ 2,358,403 total(indirect: See footnote)
Footnotes (5)
- [F1]Represents (i) 271,427 shares purchased by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and (ii) 3,270 shares purchased by Claremount VII Associates, L.P. ("Claremount VII"). The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.12 to $15.11, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 1,973,894 shares are held directly by Thrive VII Growth and 23,782 shares are held directly by Claremount VII.
- [F2]Shares held directly by Thrive VII Growth and Claremount VII. Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII Growth. Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of each of Thrive Partners VII Growth and Thrive Partners VII and, in his capacity as managing member, has voting and investment power over the shares held by each of Thrive VII Growth and Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth and Claremount VII except to the extent of their pecuniary interest therein.
- [F3]Represents (i) 54,531 shares purchased by Thrive VII Growth and (ii) 657 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.12 to $15.39, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 2,028,425 shares are held directly by Thrive VII Growth and 24,439 shares are held directly by Claremount VII.
- [F4]Represents (i) 92,719 shares purchased by Thrive VII Growth and (ii) 1,117 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.12 to $15.115, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 2,121,144 shares are held directly by Thrive VII Growth and 25,556 shares are held directly by Claremount VII.
- [F5]Represents (i) 209,183 shares purchased by Thrive VII Growth and (ii) 2,520 shares purchased by Claremount VII. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.12 to $15.81, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations and requirements of Rule 10b-18. Following the reported transaction, 2,330,327 shares are held directly by Thrive VII Growth and 28,076 shares are held directly by Claremount VII.
Documents
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001841808
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 7:56 PM ET
- Size
- 19.9 KB